Health‐related quality of life · people with asthma
Vilanterol and fluticasone furoate showed no clear difference in health‐related quality of life compared with placebo (moderate certainty).
1 finding from 1 review
MD 0.3
2012 participants
Moderate
Quality of life ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: Dermatology Quality of Life measure · participants with hidradenitis suppurativa
1 finding from 1 review
Health‐related quality of life · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · people with bronchiectasis
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Health‐related quality of life · healthy participants or recruited among the general population; individuals diagnosed with a specific disease in a stable phase or with…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · anemia in patients with rheumatoid arthritis
1 finding from 1 review
Health‐related quality of life · patients with type 2 diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health related quality of life · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Health related quality of life · patients with chronic cout
The review found no eligible studies for this question.
1 finding from 1 review
Health related quality of life · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life EORTC QLQ‐BN 20 · people with a primary brain tumour
1 finding from 1 review
Disease‐related quality of life · participants with olfactory dysfunction following COVID‐19 for ≤ 15 days
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐related quality of life · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life3 · Treatment‐naïve metastatic renal cell carcinoma (clear cell type)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (at the time of · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life Scale: 0 to 100 · patients with stable angina pectoris
1 finding from 1 review
QoL · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
The review found no eligible studies for this question.
1 finding from 1 review
QoL · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
The review found no eligible studies for this question.
1 finding from 1 review